Glaxo, Novartis get US grants to make vaccines

WASHINGTON, June 19: Pharmaceutical companies including GlaxoSmithKline PLC and Novartis AGwill get government grants to help develop medicines against pandemics and bioterrorist threats, the U.S. Government said on Monday. The two drugmakers - among the world�s largest vaccine makers - as well as US-based Emergent Biosolutions Inc will work with US universities and smaller biotechnology companies at one of three centers to develop and manufacture the medicines.